HHLA2 predicts improved prognosis of anti-PD-1/PD-L1 immunotherapy in patients with melanoma

por Huang, Fu-xue, Wu, Jun-wan, Cheng, Xia-qin, Wang, Jiu-hong, Wen, Xi-zhi, Li, Jing-jing, Zhang, Qiong, Jiang, Hang, Ding, Qiu-yue, Zhu, Xiao-feng, Zhang, Xiao-shi, Ding, Ya, Li, Dan-dan
Publicado 2022